[Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
Meningitis caused by Neisseria meningitidis is one of the most frequent and most serious, with fatal rate between few up to 20%. Majority of cases are caused by Neisseria meningitidis of serological groups A, B, C, as well as Y and W 135. Vaccination is the most effective prophylactic measure against meningococcal meningitidis. Polysaccharide, not conjugated vaccines against Neisseria meningitidis serological groups A, C, W 135, Y effective for children over 2 years old, adolescents and adults as well as vaccine against serogroup C conjugated with protein carrier, effective for children over 2 months of life, adolescents and adults are used. Conjugated vaccine against serological group C was used in 1998/1999 in Great Britain in the mass vaccination of infants in 2, 3, 4 months of life, children and adolescents up to 17. In Poland as well as in other European countries serological group B is an etiological factor of majority of cases caused by Neisseria meningitidis. Intensive studies are performed in the field on effective, safety, cheap vaccine against all serological groups of Neisseria meningitidis.
Magdzik
Wiesław
W
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005060:Europe / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage* / Q000592:standards; D009345:Neisseria meningitidis / Q000302:isolation & purification; D011044:Poland / Q000453:epidemiology; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage; D018074:Vaccines, Conjugate / Q000008:administration & dosage
D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; D018074:Vaccines, Conjugate